The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC
Official Title: A Phase III, Double-Blind, Randomised Study Comparing ZD1839 (IressaTM) Versus Placebo As Maintenance Therapy In Subjects With Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC) After Combined Modality Therapy
Study ID: NCT00234468
Brief Summary: The aim of the study if to determine if Iressa can prolong the period of time without any disease worsening (Time to progression) in patients previously treated with combined therapy such as surgery and chemotherapy with or without radiotherapy or chemotherapy and radiotherapy
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Avellino, , Italy
Research Site, Bergamo, , Italy
Research Site, Bologna, , Italy
Research Site, Cagliari, , Italy
Research Site, Campobasso, , Italy
Research Site, Catania, , Italy
Research Site, Catanzaro, , Italy
Research Site, Chieti, , Italy
Research Site, Cosenza, , Italy
Research Site, Della Fratte, , Italy
Research Site, Emilia, , Italy
Research Site, Fano, , Italy
Research Site, Firenze, , Italy
Research Site, Forli, , Italy
Research Site, Frattamaggiore, , Italy
Research Site, Livorno, , Italy
Research Site, Messina, , Italy
Research Site, Milano, , Italy
Research Site, Napoli, , Italy
Research Site, Novara, , Italy
Research Site, Orbassano, , Italy
Research Site, Padova, , Italy
Research Site, Palermo, , Italy
Research Site, Pavia, , Italy
Research Site, Potenza, , Italy
Research Site, Ravenna, , Italy
Research Site, Rimini, , Italy
Research Site, Roma, , Italy
Research Site, San Giovanni Rotondo, , Italy
Research Site, Sassari, , Italy
Research Site, Taormina, , Italy
Research Site, Venezia-Mestre, , Italy
Name: Lucio Crino, MD
Affiliation: Bologna Italy
Role: PRINCIPAL_INVESTIGATOR